The allergenis peanut diagnostic is a high-throughput multiplex Luminex bead-based epitope assay enabling clear quantification of individual linear epitope reactivity across multiple peanut allergen proteins. The test generates a highly reliable and reproducible patient reactivity signature with greater sensitivity of epitope detection compared to peptide microarrays and component resolved diagnostics.

• Application Area: Allergy
• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: United States, Europe
• Regulatory Classification: IVD

Ampersand Biosciences offers sample testing for hamster, mouse, canine, and rat serum and fluids in their GLP facility. The Luminex assays they have developed use low sample volumes and are fully validated. They offer rapid turnaround times and quality data that you can trust. Learn more about their sample testing options:

• Hamster MAP 1.0 Sample Testing
• Mouse MAP 4.1 Sample Testing

• Target: Protein
• Primary Business: Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

ARUP Laboratories provides reference testing services for immunology and autoimmune disease.

• Application Area: Autoimmune
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Quantify over 500 different protein and peptide targets simultaneously in a single 12.5 µl sample using the Bio-Plex^®Multiplex System, powered by Luminex xMAP^® Technology. The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples.

• Application Area: Autoimmune, Biomarker Screening, Cardiovascular, Infectious Disease, Oncology
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD, RUO

GuangZhou BioBlue Technology Co., LTD provides diagnostic oncology kits for immunoassay auto-antibodies against lung cancer antigens in China.

• Application Area: Oncology
• Target: Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Biopredia Biological Technology Co. Ltd develops protein IVD kits for cytokines, sex hormones, and thyroid function hormones for use in China.

• Target: Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Biovet operates laboratories at the cutting edge of technology and offers a complete range of analyses in the food-processing domain such as: microbiological analyses (culture and PCR), detection of food contaminants, mycotoxins, GMO, allergens, and more.

• Application Area: Food Safety / Production Animal
• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global

Charles River Labs offers research animal diagnostic services built on a foundation of contamination prevention measures, effective pathogen detection, and scientific and technical proficiency. Their animal diagnostic laboratory delivers sensitive and specific testing to screen your animal facility, research biologics, and different species of animal models.

• Application Area: Laboratory Animal Testing
• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

Cornell University provides infectious disease testing services for companion animals.

• Application Area: Companion Animal Testing
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

Daan Gene Co., LTD. of Sun Yat-Sen University provides kits for screening SNPs in Thalasemia in China.

• Application Area: Hereditary Diseases
• Target: Nucleic Acid
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

DESTINA offers a complete miRNA-122 profiling service combining its ChemiRNA^™ Tech with the highly sensitive Luminex^® systems (MAGPIX^®, FLEXMAP 3D^®). Cell supernatants and lysates, plasma and serum samples can be prepared and delivered using DESTINA Stabiltech buffer without the need for expensive refrigerated transport. miRNA-122 can then be detected and quantified directly from these biological samples without the need for extraction, reverse transcription or amplification using standard Luminex system workflows.

• Application Area: Biomarker Screening
• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Europe
• Regulatory Classification: IVD, RUO

DiaCarta creates kits and provides testing services for cancer applications.

• Application Area: Oncology
• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Europe, United States
• Regulatory Classification: IVD

EpiCypher works with leaders in the field to deliver innovative solutions that meet scientists’ most challenging research needs. With xMAP^® Technology, they provide kits and testing services for post-translational modifications, or PTMs.

• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

Eurofins Viracor has over 30 years of diagnostic innovation and specialized expertise in infectious disease, pre- and post-transplant, allergy and immunology testing for immunocompromised and critical patients, and more.

• Application Area: Allergy, Autoimmune, Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO, LDT

G&G Science Co., Ltd. is a bio-venture company that develops genetic and biomarker tests and testing services for precision medicine.

• Application Area: Biomarker Screening
• Target: Nucleic Acid
• Primary Business: Testing Services
• Market Availability: Asia-Pacific
• Regulatory Classification: RUO

The OmniPlex^™-HPV 40 Genotyping kit is a multiplex liquid-bead microarray capable of identifying 40 genotypes. The NeoPlex^™ STI Detection Kits are multiplex real-time PCR kits that can detect 7–14 STI-causing pathogens simultaneously with a single-tube PCR reaction.

• Application Area: Infectious Disease
• Target: Nucleic Acid
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development. The unique GA-map^® platform is based on a pre-targeted multiplex approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting-edge GA-map software algorithm, which enables immediate results without the need for further bioinformatics work. GA’s mission is to become the leading company for standardized gut microbiota testing worldwide, and they are committed to helping unlock and restore the human microbiome through its state-of-the-art technology.

• Application Area: Gastrointestinal, Infectious Disease
• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Europe, United States
• Regulatory Classification: IVD

Bright-Innovation BioMed is a leader in the developing and manufacturing nucleic acid products for academic and commercial application. They have developed a deafness gene assay kit based on Luminex xMAP^® Technology for multiplex detection of high frequency hearing-related gene mutations in GJB2, GJB3, SLC26A4, and mtDNA 12S rRNA, which cover the most common deafness gene mutations in Chinese population.

• Application Area: Hereditary Diseases
• Target: Nucleic Acid
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Detect infectious disease pathogens from samples that originate from commercial food production and farming. These kits are for use in animal health and food safety testing in China.

• Application Area: Food Safety / Production Animal
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific

Whatever your laboratory diagnostic or animal health monitoring needs, IDEXX stands ready with world-class expertise. Their scientific team has developed nearly all the newest technologies in the industry, including the innovative Opti-Spot^® blood collection process that uses just a simple drop of whole blood for comprehensive serology testing, and their Advantage Program that provides results in 3 business days.

• Application Area: Biomarker Screening, Companion Animal Testing, Laboratory Animal Testing
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

LIFECODES is a world-class leader in transplant diagnostics providing a broad portfolio of molecular and antibody-based assays using ELISA and xMAP^® Technology to evaluate HLA compatibility between donors and recipients. Laboratories all over the world use LIFECODES HLA serology and molecular typing assays as part of determining the best path forward for a transplant recipient.

• Application Area: HLA
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

ImmunoProfile^®'s goal is to empower people everywhere to protect themselves from infectious diseases. They do this by providing a simple and easy way to evaluate your antibody status through a Test Kit that covers 11 major vaccine checks all in one. Using a home collection kit, customers can access their results through a secure and private online portal.

• Application Area: Immune Response Screening
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO, LDT

Simultaneously detect multiple allergens in a single test with increased sensitivity, accuracy, and precision with the Multiplex Array for Indoor Allergens (MARIA^®). These kits combine the power of Indoor Biotechnologies' proprietary antibodies with xMAP^® Technology.

• Application Area: Allergy
• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

Inotiv’s full spectrum health monitoring programs aids facility managers in safeguarding the health of research colonies. Employing diverse technologies, we ensure efficient and precise detection of agents and pathogens across specie to preempt contamination. Our integrated services encompass assessment, design, testing, reporting and result interpretation for a holistic solution.

• Application Area: Laboratory Animal Testing
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

Interscientifica specializes in the research and development of clinical diagnostic products for neonatal and prenatal screening programs using dried blood spots.

• Application Area: Infectious Disease
• Target: Protein, Amino Acids, Hormones
• Primary Business: Kits
• Regulatory Classification: IVD

• Application Area: Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

• Application Area: Oncology
• Target: Nucleic Acid, Protein

The recomBead CXCL13 is a quantitative in vitro test for the detection of CXCL13 in human CSF on the basis of Luminex multiplex technology. The test system displays a very high sensitivity and precision in conjunction with a wide linear range. Due to multiplex integration, any additional controls are reduced to a minimum.

• Application Area: Infectious Disease
• Target: Protein
• Primary Business: Kits
• Market Availability: Europe
• Regulatory Classification: IVD

MilliporeSigma is a leader in biomarker immunoassays, including >200 MILLIPLEX^® multiplex kits with ~1,200 analytes across 11 species, all with best-in-class verification to ensure reproducible results you can trust. In addition, MilliporeSigma offers custom immunoassay development services and the full range of Luminex instrumentation for all your research needs.

• Application Area: Autoimmune, Biomarker Screening, Cardiovascular, Neurological, Oncology, Vaccines
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: RUO

Mosaic Diagnostics provides allergy testing services for the United States.

• Application Area: Allergy
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

AtomLife liquichip is a multi-detection product specially developed for biological assays based on xMAP^® Technology. By combining advanced fluidics, laser analysis, and high-speed digital signal processing technology with proprietary microsphere technology, xMAP Technology enables a high degree of multiplexing within a single sample volume.

• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

ColoPlex^™ provides patients and physicians a simple, accurate blood testing option to detect colorectal cancer. This early detection blood test is aimed at driving the right people to confirmatory colonoscopy, reducing overall costs of screening programs and improving patient outcomes. Utilizing a novel machine learning algorithm coupled with Luminex’s leading multiplex platform to measure numerous proteins in a single patient blood sample, ColoPlex^™ can provide more information to physicians so that they can diagnose disease early.

• Application Area: Oncology
• Target: Protein
• Primary Business: Kits
• Market Availability: Europe
• Regulatory Classification: IVD

NMI TT Pharmaservices designs, establishs, and validates miniaturized, multiplexed immunoassays for a multitude of applications such as PK/PD studies, drug-induced organ injury, pathogen infections, and protein-protein interactions. Their DigiWest^® technology is very close to western blot, but through Luminex bead-based multiplexing, the system is able to analyze up to 800 total and phospho proteins per sample in one run.

• Application Area: Biomarker Screening, Vaccines
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

Oncimmune uses xMAP^® Technology to profile autoantibodies in clinical samples in order to characterise disease and predict immune-related adverse events (irAEs) and their response to therapy. The platform allows multiplexing of antigens, enabling thousands of autoantibodies to be profiled from a small sample of serum or plasma. Learn more about Oncimmune in this blog.

• Application Area: Oncology
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

One Lambda offers the largest portfolio of assays for low- to high-resolution detection. Their selection of reagents for the LABScreen^™ line of products are powered by xMAP^®Technology. LABScreen assays produce trusted results, with consistency and high sensitivity, and are considered to be the gold standard in HLA antibody detection.

• Application Area: HLA
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

PerkinElmer’s screening solutions protect the health of pregnant women and newborn babies around the world, empowering earlier detection, enabling more effective treatment and saving lives.

• Application Area: Newborn Screening
• Target: Nucleic Acid, Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: IVD

PPD Laboratories offers a full range of services across a wide variety of vaccines from legacy childhood diseases and seasonal flu to endemic pathogens and novel therapeutic vaccines. They are dedicated to helping you achieve the highest scientific standards for your programs and gain development efficiencies that speed the introduction of life-changing vaccines.

• Application Area: Vaccines
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Prime Diagnostics is a world leader in the development and manufacturing of Luminex kits for multiplex detection and identification of plant pathogens (bacteria, viruses, fungi, viroids) and insect pests in agriculture. Location: Droevendaalsesteeg 1, PO Box 16, 6700 AA Wageningen, The Netherlands Tel: +31 317 480 613 Fax: +31 317 418 094 E-mail: primediagnostics@wur.nl Contact: Jan Bergervoet, Luminex Application and Development Specialist

• Application Area: Plant Testing
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: RUO

Prometheus Labs are a specialty clinical laboratory enabling precision-guided care in Inflammatory Bowel Disease and other GI disorders.

• Application Area: Gastrointestinal
• Target: Nucleic Acid
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Protavio uses Luminex multiplexing technology to offer novel products and services for biomarker discovery, companion diagnostics, serology, patient stratification, and compound evaluation.

• Application Area: Biomarker Screening, Vaccines
• Target: Protein
• Primary Business: Custom Assay Development, Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

QM Diagnostics specializes in health monitoring of small laboratory animals used for biomedical research. They also provide a wide range of complementary consultancy services to help their clients getting the most out of their products.

• Application Area: Laboratory Animal Testing
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

R&D Systems, a Bio-Techne brand, offers a variety of Luminex panels that span multiple species and over 450 targets. From the flexible Luminex Discovery Assay that allows you to build your own custom panel to highly optimized performance panels, you can choose the test that best fits your needs.

• Application Area: Biomarker Screening
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: RUO

• Target: Nucleic Acid, Protein
• Primary Business: Kits, Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

RD-Biotech—Research Immunoassays & Testing Services—provides a wide range of custom services for R&D applications including:

• Antigen or Antibody coupling with Luminex beads,
• Testing services for the detection and quantification of analytes, in single or multiplexed format with Luminex^® 200^™equipment, and
• Multiplexed assay development.

• Application Area: Biomarker Screening, Vaccines
• Target: Protein
• Primary Business: Custom Assay Development, Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

Rules-Based Medicine is the world’s leading multiplexed immunoassay development and testing laboratory. They have developed in-house assays for over 300 biomarker targets that are available on the Multi-Analyte Profiling (MAP) technology platform.

• Application Area: Biomarker Screening, Oncology
• Target: Protein
• Primary Business: Custom Assay Development, Testing Services
• Market Availability: Global

• Target: Nucleic Acid, Protein
• Primary Business: Testing Services
• Market Availability: Asia-Pacific
• Regulatory Classification: RUO

Sentara provides laboratory developed tests and testing services for cystic fibrosis in the United States.

• Application Area: Hereditary Diseases
• Target: Nucleic Acid
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Shanghai Iven Medical Technology Co., Ltd. is a high-tech enterprise that provides high-quality IVD medical products.

• Application Area: Oncology
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

SYNLAB Eesti is the largest medical laboratory in Estonia, providing laboratory services to family doctors and medical specialists, hospitals, occupational health care centres, and other institutions connected to the medical industry. They also supply anonymous tests for sexually transmitted diseases that can also be performed at home.

• Application Area: Infectious Disease
• Target: Nucleic Acid
• Primary Business: Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

The Tellgenplex^® HPV27 genotyping Assay is a human papillomavirus genotyping DNA detection kit for early screening of cervical cancer and to aid in the diagnosis of genital warts.

• Application Area: Oncology
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Provides Research Use Only kits and testing services of arboviral infections and biothreat agents.

• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

The FIDIS^™ system, based on xMAP^® Technology, offers high-throughput analysis power and allows a simultaneous and specific detection of multiple analytes from the same sample in a single assay. Compared to the conventional IFA or ELISA format, the FIDIS technology and its automation on the Theralis^™ platform allows the laboratory to perform analysis more rapidly, and at lower cost, than with conventional kit formats with optimum reliability.

• Application Area: Autoimmune
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Search the bead-based assays that utilize antibody-coated beads to measure and detect analytes of interest, and are ideal for use in an array of molecular research settings using magnetic, multiplex, singleplex, or custom immunoassays. You can also create custom multiplex RNA or DNA panels for use with the Invitrogen QuantiGene Plex Assay. All of these assays are compatible with all four xMAP^® instruments.

• Application Area: Autoimmune, Biomarker Screening, Cardiovascular, Hereditary Diseases, Neurological, Oncology, Vaccines
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: RUO

• Application Area: Biomarker Screening, Companion Animal Testing, Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Versiti Blood Center of Wisconsin diagnostic laboratories go beyond a test result, by providing support from their physicians and scientific directors. Their industry-leading, multidisciplinary diagnostic approach provides patient-centric insight in the fields of transfusion medicine, hematology, transplantation, and oncology.

• Target: Nucleic Acid, Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Wakunaga Pharmaceutical researches and develops HLA typing reagents and anti-HLA antigen detecting reagents. The HLA typing reagents have been used for the transplantation donor registration in the Japanese bone marrow program and for the platelet donor registration in the Japanese Red Cross Society. In addition, the anti-HLA detecting reagents have been used for testing to determine the PC-HLA supply to patients in the Japanese Red Cross Society.

• Application Area: HLA
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Through a dedicated focus on test innovation and workflow efficiency, Werfen is helping improve care for patients with autoimmune disease.

• Application Area: Autoimmune
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Perform multiple assays with a single sample using ZEUS AtheNA Multi-Lyte^® Test Systems for autoimmune and infectious diseases. Paired with the AtheNA Multi-Lyte^®Instrument, these multiplex, fluorescent, bead-based test systems offer a simple and efficient alternative to IFA and ELISA testing.

• Application Area: Autoimmune, Infectious Disease
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Zimmer Biomet provides testing services for infectious disease biomarker LDT immunoassays in synovial fluid.

• Application Area: Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Europe, United States
• Regulatory Classification: RUO